Incyte
INCY
$51.43
Share price
0.49%
Change (1 day)
-30.07%
Change (1 year)
Categories
Incyte (INCY) Fails to deliver data
Key failure to deliver metrics for Incyte:
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $72.55 M
- Last 3 months FTD volume: $81.65 M
- Last year FTD volume: $0.10 B
Failures to deliver for Incyte (INCY) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Incyte (INCY) - since 2013
Volume in USD (price x number of shares), data since 2013Incyte (INCY) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $81.62 M | 217.43% |
| 2023 | $25.71 M | 15.22% |
| 2022 | $22.31 M | -30.83% |
| 2021 | $32.26 M | -42.59% |
| 2020 | $56.2 M | 156.83% |
| 2019 | $21.88 M | -55.79% |
| 2018 | $49.49 M | 223.95% |
| 2017 | $15.27 M | -77.94% |
| 2016 | $69.25 M | 11.56% |
| 2015 | $62.07 M | -15.95% |
| 2014 | $73.85 M | 760.63% |
| 2013 | $8.58 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Novartis NVS | $30.53 M | $95.22 M | 🇨🇭 Switzerland |
 Pfizer PFE | $31.87 M | $0.32 B | 🇺🇸 USA |
 Eli Lilly LLY | $50.92 M | $0.12 B | 🇺🇸 USA |
 Amgen AMGN | $65.7 M | $0.18 B | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $0.58 M | $3.53 M | 🇺🇸 USA |
 Geron GERN | $10.22 M | $14.31 M | 🇺🇸 USA |
 CTI BioPharma
CTIC | N/A | $44.94 M | 🇺🇸 USA |
 AVEO Oncology
AVEO | N/A | $0.04 M | 🇺🇸 USA |
 Ardelyx ARDX | $8.97 M | $30.7 M | 🇺🇸 USA |